In the News: Six-year-old’s death leads to hope of new drug for childhood cancer

By | 2019-10-30T12:31:12+00:00 October 21st, 2019|

Our collaborator Dr Chris Jones and his fantastic team at The Institute of Cancer Research were profiled in The Observer for their work on DIPG with support from Abbie's Army. M4K Pharma is proud to be working with them to bring an affordable DIPG cure to patients.  

Recording of M4K Pharma’s Scientific Update Meeting – October 2nd, 2019

By | 2019-10-04T15:13:55+00:00 October 4th, 2019|

Listen to a recording of the October Monthly Scientific Meeting Listen to M4K Pharma's Scientific Update Meeting from October 2nd, 2019 where our scientists and collaborators discuss the latest progress in our Medicines4Kids project for a deadly children's brain cancer called DIPG. Everyone is invited to hear first-hand how we are developing [...]

Poster award for CRL and M4K open science collaboration

By | 2019-10-09T13:49:33+00:00 October 3rd, 2019|

Poster award for CRL and M4K open science collaboration Congratulations to Senior Scientist Stefano Levanto from Charles River Laboratories (CRL) on winning the early career poster prize for his poster describing CRL's open science collaboration with M4K Pharma at the 20th SCI/RSC Medicinal Chemistry Symposium in Cambridge, UK last month. A team of CRL medicinal chemists [...]

SGC-Oxford team comes out in support of Brain Tumour Charity’s Twilight Walk

By | 2019-10-03T11:45:04+00:00 October 1st, 2019|

SGC-Oxford team comes out in support of Brain Tumour Charity's Twilight Walk On September 29th 2019, the Brain Tumour Charity organized The Twilight Walk in Warwick, UK, to raise funds for research and patient support. M4K Pharma's DIPG project collaborators at the Structural Genomics Consortium (SGC)- University of Oxford took part in the event by [...]